全科医生在心房颤动综合管理中的作用

刘露; 刘晓宇

doi:10.16766/j.cnki.issn.1674-4152.002110

全科医生在心房颤动综合管理中的作用

doi: 10.16766/j.cnki.issn.1674-4152.002110

刘露,
刘晓宇^,

河南大学人民医院河南省人民医院全科医学科，河南郑州 450003

基金项目:

2020年河南省医学适宜技术推广项目 SYJS2020026

详细信息

通讯作者:
刘晓宇,E-mail: chinaliuxiaoyu@126.com

中图分类号: R541.7 R499
计量
- 文章访问数: 189
- HTML全文浏览量: 74
- PDF下载量: 19
- 被引次数: 0
出版历程
- 收稿日期: 2020-10-25
- 网络出版日期: 2022-02-15

Role of general practitioners in the integrated management of atrial fibrillation

LIU Lu,
LIU Xiao-yu^,

Department of General Practice, Henan University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, China

摘要

摘要: 心房颤动(房颤)是一种临床常见的心律失常，常引起心悸、乏力、胸闷等症状，房颤患者发生卒中、心衰风险增加数倍。在传统的房颤防治模式下，虽然新型口服抗凝药、左心耳封堵术及导管消融术等新治疗方法不断出现，患者的全因死亡率并未得到明显改善，其致残率仍呈上升趋势，医疗负担持续加重，房颤已成为危害人民群众健康的重大公共卫生问题。房颤综合管理是近年提出并证实可明显降低房颤患者住院率及死亡率的治疗策略。该策略需组建一支由全科医生、卒中专家、心脏内科、心脏外科、药学专家等组成的多学科团队，对房颤患者进行综合、全面、连续地管理。全科医生在房颤一级预防中可对其危险因素进行筛查、评估，对居民进行健康教育，促进生活方式、饮食方式的改善，从而控制或消除危险因素对房颤的影响；在房颤二级预防中通过常规体检、门诊复诊等方式做到房颤的早期发现、早期诊断、早期治疗；对已发生房颤的患者，全科医生通过及时有效的抗凝、控制心室率、维持窦性心律等治疗与监测，防治卒中、心衰、出血等并发症。本文从房颤综合管理角度，通过对全科医生在房颤各级预防中的角色进行梳理分析，以期为基层全科医生在房颤管理中的工作方向及流程提供参考和依据。
- 心房颤动 /
- 综合管理 /
- 全科医生 /
- 房颤预防
Abstract: Atrial fibrillation (AF) is an important and highly prevalent arrhythmia that increases the risk of stroke and heart failure. It is also associated with palpitation, fatigue and chest tightness. Despite the development of treatment methods such as non-vitamin K antagonist oral anticoagulant, left atrial appendage closure and catheter ablation, the all-cause mortality has not been significantly improved, and the disability rate is still on the rise under traditional treatment modes of AF. AF poses a significant burden to patients and healthcare systems globally. The integrated management of AF has been proposed and proved to significantly reduce hospitalisation and mortality. Integrated AF management requires a coordinated multidisciplinary team composed of general practitioners, stroke specialists, cardiologists, cardiac surgeons and pharmacists to manage patients with AF synthetically, comprehensively and continuously. In the primary prevention of AF, general practitioners can screen and evaluate the risk factors, provide health education to residents and promote a healthy lifestyle and diet, so as to control or eliminate the impact of risk factors on AF. In the secondary prevention of AF, the early detection, diagnosis and treatment of AF can be achieved through routine physical examination and outpatient follow-up. For patients with AF, general practitioners can prevent stroke, heart failure, bleeding and other complications through timely and effective anticoagulation, symptom control with rate or rhythm control treatment and monitoring. From the perspective of integrated management of AF, this article analyses the role of general practitioners in the prevention of AF and provides the basis for the process of general practitioners in the management of AF.
- Atrial fibrillation /
- Integrated management /
- General practitioners /
- Prevention of atrial fibrillation

HTML全文

参考文献(43)

[1]	DAI H, ZHANG Q, MUCH A A, et al. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: Results from the Global Burden of Disease Study 2017[J]. Eur Heart J Qual Care Clin Outcomes, 2020. DOI: 10.1093/ehjqcco/qcaa061.
[2]	WANG Z, CHEN Z, WANG X, et al. The disease burden of atrial fibrillation in China from a national cross-sectional survey[J]. Am J Cardiol, 2018, 122(5): 793-798. doi: 10.1016/j.amjcard.2018.05.015
[3]	JOSEPH P G, HEALEY J S, RAINA P, et al. Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153, 152 middle-aged individuals[J]. Cardiovasc Res, 2020. DOI:10.1093/cvr/cvaa 241.
[4]	WANG X, FU Q, SONG F, et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey[J]. Int J Cardiol, 2018, 271: 92-97. doi: 10.1016/j.ijcard.2018.05.131
[5]	LI Y G, LIP G Y H. Stroke prevention in atrial fibrillation: State of the art [J]. Int J Cardiol, 2019, 287: 201-209. doi: 10.1016/j.ijcard.2018.09.057
[6]	RUDDOX V, SANDVEN I, MUNKHAUGEN J, et al. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis[J]. Eur J Prev Cardiol, 2017, 24(14): 1555-1566. doi: 10.1177/2047487317715769
[7]	STAERK L, SHERER J A, Ko D, et al. Atrial fibrillation: Epidemiology, pathophysiology, and clinical outcomes[J]. Circ Res, 2017, 120(9): 1501-1517. doi: 10.1161/CIRCRESAHA.117.309732
[8]	CHUGH S S, HAVMOELLER R, NARAYANAN K, et al. Worldwide epidemiology of atrial fibrillation: A global burden of disease 2010 study[J]. Circulation, 2014, 129(8): 837-847. doi: 10.1161/CIRCULATIONAHA.113.005119
[9]	JANUARY C T, WANN L S, CALKINS H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association task force on clinical practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons [J]. Circulation, 2019, 140(2): e125-e151. http://www.sciencedirect.com/science/article/pii/S1547527119300372
[10]	黄从新, 张澍, 黄德嘉, 等. 心房颤动: 目前的认识和治疗建议(2018)[J]. 中华心律失常学杂志, 2018, 22(4): 279-346. doi: 10.3760/cma.j.issn.1007-6638.2018.04.002
[11]	HINDRICKS G, POTPARA T, DAGRES N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)[J]. Eur Heart J, 2020, 42(5): 373-498. http://d.wanfangdata.com.cn/periodical/7b60f7723a742343d756f8a32ff23250
[12]	POKORNEY S D, PICCINI J P, STEVENS S R, et al. Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF[J]. J Am Heart Assoc, 2016, 5(3): e002197. http://dash.harvard.edu/bitstream/handle/1/27822378/4943233.pdf?sequence=1
[13]	HENDRIKS J M L, TIELEMAN R G, VRIJHOEF H J M, et al. Integrated specialized atrial fibrillation clinics reduce all-cause mortality: Post hoc analysis of a randomized clinical trial[J]. Europace, 2019, 21(12): 1785-1792. doi: 10.1093/europace/euz209
[14]	GALLAGHER C, ELLIOTT A D, WONG C X, et al. Integrated care in atrial fibrillation: A systematic review and meta-analysis[J]. Heart, 2017, 103(24): 1947-1953. http://heart.bmj.com/content/103/24/1947.full.pdf
[15]	PROIETTI M, ROMITI G F, OLSHANSKY B, et al. Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the simple ABC (Atrial Fibrillation Better Care) pathway[J]. Am J Med, 2018, 131(11): 1359-1366. doi: 10.1016/j.amjmed.2018.06.012
[16]	KIRCHHOF P, BENUSSI S, KOTECHA D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Europace, 2016, 18(11): 1609-1678. doi: 10.1093/europace/euw295
[17]	GORENEK B, PELLICCIA A, BENJAMIN E J, et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)[J]. Eur J Prev Cardiol, 2017, 24(1): 4-40. doi: 10.1177/2047487316676037
[18]	SHARASHOVA E, WILSGAARD T, BALL J, et al. Long-term blood pressure trajectories and incident atrial fibrillation in women and men: The TromsØ Study [J]. Eur Heart J, 2020, 41(16): 1554-1562. doi: 10.1093/eurheartj/ehz234
[19]	SOLIMAN E Z, RAHMAN A F, ZHANG Z M, et al. Effect of intensive blood pressure lowering on the risk of atrial fibrillation[J]. Hypertension, 2020, 75(6): 1491-1496. doi: 10.1161/HYPERTENSIONAHA.120.14766
[20]	AUNE D, FENG T, SCHLESINGER S, et al. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies[J]. J Diabetes Complications, 2018, 32(5): 501-511. doi: 10.1016/j.jdiacomp.2018.02.004
[21]	SEYED A S, SVENSSON A M, PIVODIC A, et al. Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: A swedish cohort study[J]. Cardiovasc Diabetol, 2020, 19(1): 9. doi: 10.1186/s12933-019-0983-1
[22]	YANG S, CHOI E K, HAN K D, et al. Risk of atrial fibrillation in relation to the time course of type 2 diabetes mellitus and fasting blood glucose[J]. Am J Cardiol, 2019, 124(12): 1881-1888. doi: 10.1016/j.amjcard.2019.09.009
[23]	LAVIE C J, PANDEY A, LAU D H, et al. Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: Effects of weight loss and exercise[J]. J Am Coll Cardiol, 2017, 70(16): 2022-2035. doi: 10.1016/j.jacc.2017.09.002
[24]	KENDZERSKA T, GERSHON A S, ATZEMA C, et al. Sleep apnea increases the risk of new hospitalized atrial fibrillation: A historical cohort study[J]. Chest, 2018, 154(6): 1330-1339. doi: 10.1016/j.chest.2018.08.1075
[25]	JOHANSSON C, LIND M M, ERIKSSON MARIE, et al. Alcohol consumption and risk of incident atrial fibrillation: A population-based cohort study[J]. Eur J Intern Med, 2020, 76: 50-57. doi: 10.1016/j.ejim.2020.02.022
[26]	MIDDELDORP M E, ARIYARATNAM J, LAU D, et al. Lifestyle modifications for treatment of atrial fibrillation[J]. Heart, 2020, 106(5): 325-332. doi: 10.1136/heartjnl-2019-315327
[27]	JIANG C, LAN D, DU X, et al. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study [J]. J Cardiovasc Electrophysiol, 2019, 30(12): 2759-2766. doi: 10.1111/jce.14231
[28]	吴书林. 重视心房颤动的上游治疗[J]. 中华心血管病杂志, 2020, 48(12): 993-994. doi: 10.3760/cma.j.cn112148-20201102-00875
[29]	刘松涛, 罗潇, 李萍. 心房颤动上游治疗的研究进展[J]. 中华全科医学, 2018, 16(11): 1886-1889. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201811035.htm
[30]	刘彤, 陈子良. 生活方式改变上游药物治疗对心房颤动的预防和治疗证据[J]. 中国实用内科杂志, 2020, 40(3): 182-186. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK202003003.htm
[31]	国家卫生健康委办公厅, 国家中医药管理局办公室. 《关于印发心房颤动分级诊疗服务技术方案的通知》(国卫办医函[2019]710号)[EB/OL]. (2019-09-05)[2020-09-21]. http://www.nhc.gov.cn/yzygj/s3594q/201909/592e8b8ac8044617bc9ed9186c2ee19f.shtml.
[32]	中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 心房颤动基层诊疗指南(2019年)[J]. 中华全科医师杂志, 2020, 19(6): 465-473. doi: 10.3760/cma.j.cn114798-20191118-00838
[33]	基层心血管病综合管理实践指南2020[J]. 中国医学前沿杂志(电子版), 2020, 12(8): 1-73.
[34]	MAIRESSE G H, MORAN P, VAN GELDER I C, et al. Screening for atrial fibrillation: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) [J]. Europace, 2017, 19(10): 1589-1623. doi: 10.1093/europace/eux177
[35]	PEREZ M V, MAHAFFEY K W, HEDLIN H, et al. Large-Scale assessment of a smartwatch to identify atrial fibrillation[J]. N Engl J Med, 2019, 381(20): 1909-1917. doi: 10.1056/NEJMoa1901183
[36]	白重阳, 张惠中. 华法林对房颤患者的凝血功能血小板参数以及血流变化的影响[J]. 河北医学, 2020, 26(1): 173-176. doi: 10.3969/j.issn.1006-6233.2020.01.042
[37]	倪岚, 薛锦花, 薛峰. 上海市浦东新区全科医生心房颤动认识的现状调查[J]. 中华全科医师杂志, 2018, 17(11): 895-900. doi: 10.3760/cma.j.issn.1671-7368.2018.11.008
[38]	BAI Y, WANG Y L, SHANTSILA A, et al. The global burden of atrial fibrillation and stroke: A systematic review of the clinical epidemiology of atrial fibrillation in Asia [J]. Chest, 2017, 152(4): 810-820. doi: 10.1016/j.chest.2017.03.048
[39]	国家心血管病医疗质量控制中心专家委员会心房颤动专家工作组. 2019年中国心房颤动医疗质量控制报告[J]. 中国循环杂志, 2020, 35(5): 427-437. doi: 10.3969/j.issn.1000-3614.2020.05.003
[40]	张凤艳, 冯天元, 徐建, 等. 农村社区房颤患者综合管理效果评价[J]. 浙江临床医学, 2018, 20(10): 1678-1680.
[41]	颜骅, 施建华, 周剑峰, 等. 社区脑卒中患者各级康复准入及准出标准建立研究[J]. 中国全科医学, 2019, 22(20): 2398-2405. doi: 10.12114/j.issn.1007-9572.2019.00.174
[42]	LONG L, MORDI I R, BRIDGES C, et al. Exercise-based cardiac rehabilitation for adults with heart failure[J]. Cochrane Database Syst Rev, 2019, 1(1): CD003331. http://www.researchgate.net/publication/330733496_Exercise-based_cardiac_rehabilitation_for_adults_with_heart_failure
[43]	JONES B, MCCLEAN S, STANFORD D. Modelling mortality and discharge of hospitalized stroke patients using a phase-type recovery model[J]. Health Care Manag Sci, 2019, 22(4): 570-588. doi: 10.1007/s10729-018-9446-6